Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Response from Spectral wrt to Dialco

<< Previous

Bullboard Posts

Next >>

Comment by Quackeron Jan 17, 2023 7:46am

173 Views

Post# 35227271

RE:RE:Response from Spectral wrt to Dialco

Excellent post. Management should immediately release all information on the sale of DIMI and Sami.

This is really starting to smell. Should we be wary of our other Asset and what may happen to it???

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market